Abstract |
The μ1 opioid receptor (OPRM1) genetic variant A118G results in decreased μ-receptor binding potential in the brain and increases morphine requirement. We hypothesized that OPRM1 A118G polymorphism will affect morphine-induced respiratory depression (MIRD) risk in children receiving morphine. A prospective genotype-blinded study was conducted in 88 healthy adolescents (11-18 years; 67% female, 85% Caucasian) who underwent spine fusion for scoliosis. They were followed for 48 h postoperatively for MIRD, pain scores, morphine consumption and use of analgesic adjuvants. Patients were genotyped for OPRM1 A118G variant-76% were wild type (AA) and 24% heterozygous/homozygous for variant (AG/GG). Multivariable logistic regression showed that the risk of MIRD in patients with AA genotype was significantly higher (odds ratio 5.6, 95% CI: 1.4-37.2, P=0.030). Presence of G allele was associated with higher pain scores (effect size 0.73, P=0.045). This novel association is an important step toward predicting MIRD susceptibility and personalizing morphine use.
|
Authors | V Chidambaran, J Mavi, H Esslinger, V Pilipenko, L J Martin, K Zhang, S Sadhasivam |
Journal | The pharmacogenomics journal
(Pharmacogenomics J)
Vol. 15
Issue 3
Pg. 255-62
(Jun 2015)
ISSN: 1473-1150 [Electronic] United States |
PMID | 25266679
(Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics, Opioid
- OPRM1 protein, human
- Receptors, Opioid, mu
- Morphine
|
Topics |
- Adolescent
- Alleles
- Analgesics, Opioid
(administration & dosage, adverse effects)
- Child
- Female
- Genotype
- Homozygote
- Humans
- Male
- Morphine
(administration & dosage, adverse effects)
- Polymorphism, Single Nucleotide
(genetics)
- Prospective Studies
- Receptors, Opioid, mu
(genetics, metabolism)
- Respiratory Insufficiency
(chemically induced, genetics, metabolism)
- Risk
- Scoliosis
(surgery)
- Spine
(surgery)
|